KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,136 | -7.3% | 5,096 | -6.2% | 0.01% | 0.0% |
| Q2 2023 | $637,717 | +52.5% | 5,432 | +4.0% | 0.01% | +25.0% |
| Q1 2023 | $418,073 | +4.1% | 5,222 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $401,566 | +18.1% | 5,069 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $340,000 | +9.7% | 4,876 | +3.3% | 0.00% | +33.3% |
| Q2 2022 | $310,000 | -1.3% | 4,718 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $314,000 | +15.4% | 4,712 | +21.3% | 0.00% | +50.0% |
| Q4 2021 | $272,000 | +32.7% | 3,885 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $205,000 | -22.1% | 3,931 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $263,000 | -8.4% | 3,873 | +3.9% | 0.00% | -33.3% |
| Q1 2021 | $287,000 | +29.3% | 3,729 | +0.6% | 0.00% | +50.0% |
| Q4 2020 | $222,000 | – | 3,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |